Now that NIH NCATS Is Replacing NCRR, Where Have The NCRR Programs Gone?

By Bouvier Grant Group

We stay current on NIH happenings and would be delighted to keep you informed.

It has been over a year since NIH Director Francis Collins announced the creation of the National Center for Advancing Translational Science. From the NIH website:  “The goal of NCATS will be to develop new ways of doing translational research that the public and private research and development communities can adopt. Innovations that come out of NCATS are intended to cut down the time or expense needed to develop a new drug, or allow us to predict which compounds will work best and be safe earlier in development.”

CLICK HERE for more information on the mission of NCATS.

One casualty of the formation of NCATS has been the National Center for Research Resources (NCRR.) Where have the NCRR programs gone? Two have wound up at NIGMS. From a NIGMS blog post by Judith Greenberg:

“In the first major reorganization of NIGMS since 1994, we have just established two new divisions that bring together existing NIGMS programs with programs transferred to NIGMS from the former National Center for Research Resources (NCRR). These changes give us the opportunity to create synergies and strengthen efforts in areas that are central to our mission.

“The Division of Training, Workforce Development, and Diversity (TWD) merges NIGMS research training programs with activities that were previously in the Institute’s Division of Minority Opportunities in Research (MORE). It also houses the Institutional Development Award program from NCRR. Our decision to create this division was informed by input we received from many stakeholders, and it responds to key goals and recommendations of our strategic plans. Its director is Clif Poodry, who formerly directed the MORE Division.

“The Division of Biomedical Technology, Bioinformatics, and Computational Biology (BBCB) combines programs of our Center for Bioinformatics and Computational Biology (CBCB) with biomedical technology programs from NCRR. Karin Remington, who previously directed CBCB, is the director of this new division.

“You might be wondering what the reorganization will mean for your current or future funding. The amount of money allocated to programs in the new divisions will not change as a result of the reorganization or the transfer of NCRR programs to NIGMS. The review of applications will stay the same, too, as will most of the staff who manage the grants and review the applications.”

 

Author:
Dr. Meg Bouvier

Margaret Bouvier received her PhD in 1995 in Biomedical Sciences from the Mount Sinai School of Medicine. After an NINDS post-doctoral fellowship, she worked as a staff writer for long-standing NIH Director Dr. Francis Collins in the Office of Press, Policy, and Communications for the Human Genome Project and NHGRI. Since 2007, Meg has specialized in editing and advising on NIH submissions, and began offering virtual courses in 2015. She's recently worked with more than 40% of the nation's highest-performing hospitals*, four of the top 10 cancer hospitals, three of the top five medical schools for research, and 14 NCI-designated cancer centers. Her experience at NIH as both a bench scientist and staff writer greatly informs her approach to NIH grantwriting. She has helped clients land over half a billion in federal funding. Bouvier Grant Group is a woman-owned small business.

*Our clients include 9 of the top 22 hospitals as recognized by the 2023/24 US News & World Report honor roll

Categories:
We read all NIH notices for our clients. When you join our mailing list, we’ll pass along important changes directly to your inbox, as well as opportunities to improve your grantsmanship skills.
Primary Position
Lead Source

Wait!

Subscribe to our monthly newsletter for the latest NIH news, grantwriting tips, and more.

NIH-October-2023-Newsletter